Regulatory and Approval Reality Regulatory status is a hard fact that does not depend on mechanistic promise, so it is worth stating plainly
All dosages were generally well tolerated, with gastrointestinal symptoms being the most frequently reported adverse effect
In addition, small molecule inhibitors including SLC7A11 inhibitor HG106 and GCLC inhibitor buthionine sulfoximine (BSO) were introduced to investigate their effects on ROS, GSH levels and cellular viability in VRK2-KO and VRK2-KD cells, and the results were consistent with the above knockdown experiment (Fig
(2025) Nat Commun 16 : 3389-3389 PubMed: 40204768 Search on PubMedSearch on PubMed Central DOI: Primary Citation Related Structures: 9BLB, 9BLC, 9BLW, 9BP3, 9BQ3, 9BTW, 9BUB, 9BUC, 9BUD, 9BUE PubMed Abstract: Obesity is a major and increasingly prevalent chronic metabolic disease with numerous comorbidities